πŸš‘πŸ“ˆπŸ’Š UnitedHealth Ignites a Healthcare Wedge Breakout πŸš‘πŸ“ˆπŸ’Š

Barcode
09-09

$UnitedHealth(UNH)$ $Direxion Daily Healthcare Bull 3X Shares(CURE)$ I’m fully convinced this move in UnitedHealth ($UNH) isn’t just noise; it’s the ignition point that could reshape healthcare momentum across both single-stock and leveraged ETF structures.

πŸ’‘ UnitedHealth Inverse Head & Shoulders (Micro Frame)

This morning’s price action confirmed the bullish IHS breakout with $318 now acting as the inflection pivot. As long as that level holds, the setup points toward $325–$330. Options flow backs it up: calls are leading with a 0.28 put/call ratio, IV30 elevated to 34.33, and expected daily swings near $6.90. The skew flattening signals traders aren’t hedging downside, they’re leaning into upside continuation.

πŸ“Š ETF Transmission via $CURE (Macro Frame)

Here’s where it gets powerful: the move in UNH directly lifts $CURE, the 3x healthcare ETF. Your monthly wedge chart shows CURE resting right on structural support, with multiple ascending trendlines ready to converge into a larger move. This isn’t random chop; it’s an inflection. $CURE has short-term resistance near $81.50 and base support at $78.50, but the bigger picture wedge suggests room for a breakout leg much higher if UNH leads.

πŸ”Ž Keltner & Bollinger Confirmation

On both UNH and CURE, the Keltner/Bollinger overlays show price pushing against the mid-to-upper bands. For UNH, compression resolved higher and is trending into expansion. For CURE, the tape is tighter but now basing for a directional shift: the ETF is coiling for energy. If UNH sustains leadership, CURE’s compression won’t stay sideways for long.

πŸ₯ Buffett Effect & Healthcare Positioning

Buffett’s conviction in UNH adds institutional weight behind this move. Healthcare’s defensive cashflow base plus leveraged ETF transmission gives traders multiple ways to scale conviction: direct exposure via UNH or magnified upside through CURE. The dual-frame read says one thing: the path of least resistance is up.

New $1.93B stake in UnitedHealth $UNH

🧭 Strategic Takeaway

I’m aligning with healthcare here: UNH above $318 anchors the entire thesis, while CURE’s wedge setup provides the asymmetric kicker. This is how micro-structure breakouts flow into macro ETF expansions.

πŸ”₯ Conclusion

The healthcare sector is quietly setting up for a breakout cycle with UNH as the anchor and CURE as the amplifier. Momentum, structure, and flow all align. This isn’t just a bounce, it’s a roadmap for traders looking to position into strength.

πŸ‘‰β“Do you see healthcare as one of the strongest asymmetric plays heading into September, or are you leaning toward other sectors for leadership?

πŸ“’ Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets πŸš€πŸ“ˆ I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! πŸ€

Trade like a boss! Happy trading ahead, Cheers, BC πŸ“ˆπŸš€πŸ€πŸ€πŸ€

@Tiger_comments @TigerWire @TigerStars @TigerPM @Daily_Discussion @TigerObserver @1PC 

Berkshire invests in UnitedHealth Group, stock jumps premarket
Berkshire opens position in UnitedHealth in Q2, sends stock up 12.2% premarket
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Hen Solo
    09-09
    Hen Solo
    πŸ“ˆYour focus on Keltner and Bollinger overlays hits the mark. The compression-expansion dynamic is what I watch in $XLV too, and you’re right, once leadership shows up in a defensive giant like UNH, the ETF bid usually follows. Strong connection between micro and macro frames.
    • Barcode:Β 
      You’re spot on with the compression-expansion cycle. $XLV often tracks that pattern and with UNH driving, the ETF bid aligns. Holding $318 sets up the move for CURE to break its wedge, which ties the micro technicals into a broader macro rally.
    • Barcode:Β 
      🩺 πŸ…—πŸ…πŸ…ŸπŸ…ŸπŸ…¨ β“‰β“‘β“β““β“˜β“β“– πŸ…πŸ…—πŸ…”πŸ…πŸ…“! πŸ…’πŸ…—πŸ…”πŸ…”πŸ…‘πŸ…’ πŸ…‘πŸ…’ πŸ€πŸ€πŸ€πŸŸ’
    • Barcode:Β 
      I’m grateful you took time to go through my post HS. The more we can exchange thoughtful ideas, the better we can navigate both the opportunities and the risks in markets like these.
  • Cool Cat Winston
    09-09
    Cool Cat Winston
    πŸ“ŠI like how you tied UNH holding $318 into the bigger CURE wedge setup, that’s a clear roadmap. Reminds me of how $JNJ held its long-term trend last quarter and then the sector followed. The skew flattening detail really adds conviction that the upside is building here.
    • Barcode:Β 
      🩺 πŸ…—πŸ…πŸ…ŸπŸ…ŸπŸ…¨ β“‰β“‘β“β““β“˜β“β“– πŸ…πŸ…—πŸ…”πŸ…πŸ…“! πŸ…’πŸ…—πŸ…”πŸ…”πŸ…‘πŸ…’ πŸ…‘πŸ…’ πŸ€πŸ€πŸ€πŸŸ’
    • Barcode:Β 
      I agree, $JNJ’s ability to hold trend was a great parallel. When UNH anchors above $318 it gives the same sector leadership effect, and that skew flattening is telling me positioning is shifting toward an aggressive upside continuation.
    • Barcode:Β 
      I appreciate you taking the time to read my post CCW. Your engagement helps push these market discussions further, and it’s always valuable to exchange perspectives on where we might be in the cycle.
  • Tui Jude
    09-09
    Tui Jude
    The read-through from UNH’s IHS into leveraged exposure on CURE makes a lot of sense. That $81.50 resistance you flagged is key, and I like how you framed Buffett’s UNH stake as institutional weight. It feels similar to how $BRK.B steadies financials when sentiment wavers.
    • Barcode:Β 
      Exactly, Buffett’s conviction provides that stabilizing weight for UNH, much like $BRK.B does for financials. If $CURE clears $81.50 with UNH leading, I see capital rotation favoring healthcare as a leveraged way to play stability with growth.
    • Barcode:Β 
      🩺 πŸ…—πŸ…πŸ…ŸπŸ…ŸπŸ…¨ β“‰β“‘β“β““β“˜β“β“– πŸ…πŸ…—πŸ…”πŸ…πŸ…“! πŸ…’πŸ…—πŸ…”πŸ…”πŸ…‘πŸ…’ πŸ…‘πŸ…’ πŸ€πŸ€πŸ€πŸŸ’
    • Barcode:Β 
      I’m grateful you took a moment to go through my post TJ. The more we can exchange thoughtful ideas, the better we can navigate both the opportunities and the risks in markets like these.
  • Queengirlypops
    09-09
    Queengirlypops
    This read is fire, I’m vibing with the way UNH is anchoring the whole sector move and giving CURE that upside juice. $318’s like the gatekeeper and once that’s locked in, $81.50 gets tested fast. Healthcare might be the sneaky outperformer rolling into September πŸ§ƒ
    • Barcode:Β 
      🩺 πŸ…—πŸ…πŸ…ŸπŸ…ŸπŸ…¨ β“‰β“‘β“β““β“˜β“β“– πŸ…πŸ…—πŸ…”πŸ…πŸ…“! πŸ…’πŸ…—πŸ…”πŸ…”πŸ…‘πŸ…’ πŸ…‘πŸ…’ πŸ€πŸ€πŸ€πŸŸ’
    • Barcode:Β 
      I like how you framed $318 as the gatekeeper. That level is exactly where conviction builds and gives CURE the energy to test $81.50. The structure shows a defensive sector with offensive upside, and that makes healthcare a high-conviction play.
    • Barcode:Β 
      Thank you for going through my post Q. Every reader who engages with these ideas helps sharpen the market lens we’re all trying to look through together.
  • Kiwi Tigress
    09-09
    Kiwi Tigress
    Healthcare’s setting up clean, UNH holding $318 feels like the trigger that’ll drive the wedge breakout you mapped on CURE. I’m seeing the same sector energy that tech had in July, and it’s wild to think a defensive space could push momentum like this πŸ“ˆ
    • Barcode:Β 
      🩺 πŸ…—πŸ…πŸ…ŸπŸ…ŸπŸ…¨ β“‰β“‘β“β““β“˜β“β“– πŸ…πŸ…—πŸ…”πŸ…πŸ…“! πŸ…’πŸ…—πŸ…”πŸ…”πŸ…‘πŸ…’ πŸ…‘πŸ…’ πŸ€πŸ€πŸ€πŸŸ’
    • Barcode:Β 
      Yes, the parallel with July tech momentum is sharp. UNH holding $318 really is the pivot that sets the tone. The wedge setup in CURE is primed and if volume confirms, I see healthcare delivering a sector-wide upside cycle into September.
    • Barcode:Β 
      I appreciate you reading my article KT! Insights are always stronger when they’re part of a broader conversation, and your time spent here adds value to that dialogue.
  • Venus Reade
    09-09
    Venus Reade
    Just buy and hold this until next year 2026 mid, it will go back to mid $600 as all the DOJ frauds going to be scrapped against this giant.

    • Barcode:Β 
      I see your point and I do think the DOJ overhang is weighing more on sentiment than on fundamentals. If regulatory pressure eases, the multiple can re-rate quickly. For me, the path back toward the $600s hinges on earnings momentum holding alongside margin stability.
    • Barcode:Β 
      🩺 πŸ…—πŸ…πŸ…ŸπŸ…ŸπŸ…¨ β“‰β“‘β“β““β“˜β“β“– πŸ…πŸ…—πŸ…”πŸ…πŸ…“! πŸ…’πŸ…—πŸ…”πŸ…”πŸ…‘πŸ…’ πŸ…‘πŸ…’ πŸ€πŸ€πŸ€πŸŸ’
    • Barcode:Β 
      I appreciate you reading through my work, every set of eyes adds more depth to the conversation.
Leave a comment
30
417